GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.20
Ask: 5.30
Change: 0.00 (0.00%)
Spread: 0.10 (1.923%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 26th Feb 2020 16:15

Thursday 27 February 
Standard CharteredFull Year Results (at 0415 GMT)
WPP Full Year Results
Flutter EntertainmentFull Year Results
Watches of SwitzerlandTrading Statement
Aston Martin LagondaFull Year Results
RSA Insurance GroupFull Year Results
WPP Full Year Results
Reckitt BenckiserFull Year Results
PersimmonFull Year Results
MondiFull Year Results
Rentokil InitialFull Year Results
St James's PlaceFull Year Results
British American TobaccoFull Year Results
InchcapeFull Year Results
Grafton GroupFull Year Results
NetcallHalf Year Results
PPHE HotelsFull Year Results
Playtech Full Year Results
Macfarlane GroupFull Year Results
Haydale GrapheneHalf Year Results
Hikma Pharmaceuticals Full Year Results
FBD HoldingsFull Year Results
Georgia CapitalFull Year Results
Drax GroupFull Year Results
Provident FinancialFull Year Results
Vistry GroupFull Year Results
VesuviusFull Year Results
RicardoFull Year Results
EvrazFull Year Results
National ExpressFull Year Results
Amigo HoldingsFull Year Results
GenusFull Year Results
HuntingFull Year Results
James Fisher & SonsFull Year Results
Hastings Group HoldingsFull Year Results
Howden Joinery GroupFull Year Results
BakkavorFull Year Results
Verona PharmaFull Year Results
Base ResourcesFull Year Results
Friday 28 February 
London Stock Exchange GroupFull Year Results
International Consolidated Airlines GroupFull Year Results
CRHFull Year Results
RightmoveFull Year Results
Rolls-Royce HoldingsFull Year Results
Glenveagh PropertiesFull Year Results
Surface TransformsHalf Year Results
Vitec Full Year Results
EssentraFull Year Results
Tetragon Financial GroupFull Year Results
IMIFull Year Results
Man GroupFull Year Results
FoxtonsFull Year Results
ConvaTec GroupFull Year Results
Jupiter Asset ManagementFull Year Results
Monday 2 March 
Johnson Service GroupFull Year Results
Greencoat RenewablesFull Year Results
HiscoxFull Year Results
Mid Wynd International Investment TrustHalf Year Results
SeniorFull Year Results
Tuesday 3 March 
IntertekFull Year Results
John Laing GroupFull Year Results
XP PowerFull Year Results
4imprint GroupFull Year Results
Cairn HomesFull Year Results
FresnilloFull Year Results
Ashtead GroupQ3 Results
Hutchison ChinaFull Year Results
Direct Line InsuranceFull Year Results
Greggs Full Year Results
HuntsworthFull Year Results
Travis PerkinsFull Year Results
GoCo GroupFull Year Results
DX GroupHalf Year Results
Robert WaltersFull Year Results
RotorkFull Year Results
KellerFull Year Results
Apax Global AlphaFull Year Results
CranewareHalf Year Results
IbstockFull Year Results
International Game TechnologyQ4 Results
IWGFull Year Results
Wednesday 4 March 
BATM AdvancedFull Year Results
Allergy TherpeutucsHalf Year Results
Hostelworld GroupFull Year Results
Mpac GroupFull Year Results
Crystal Amber FundHalf Year Results
Vivo EnergyFull Year Results
Legal & GeneralFull Year Results
Polymetal InternationalFull Year Results
TT ElectronicsFull Year Results
BiffaTrading Statement
Hill & Smith HoldingsFull Year Results
ElementisFull Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Aug 2021 14:33

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential

Read more
3 Aug 2021 13:43

Allergy Therapeutics upbeat on ex-vivo study of peanut allergy vaccine

(Sharecast News) - Pharmaceutical biotechnology company Allergy Therapeutics announced positive primary results from an ex-vivo biomarker study on Tuesday, evaluating its novel virus-like particle (VLP)-based peanut allergy vaccine candidate, VLP Peanut.

Read more
14 Jul 2021 12:29

Allergy Therapeutics expects revenue rise in year despite challenges

Allergy Therapeutics expects revenue rise in year despite challenges

Read more
24 Jun 2021 19:56

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Read more
24 Jun 2021 08:07

Allergy Therapeutics FY profits seen 'well ahead' of expectations

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said on Thursday that full-year operating profits were expected to be "well ahead" of market expectations thanks to "significantly lower" expenses.

Read more
6 May 2021 19:25

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

Read more
6 May 2021 15:34

Allergy Therapeutics completes treatment in G309 field study

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics announced the completion of the treatment of all patients in its 'G309' exploratory field study to evaluate the efficacy and safety of Grass MATA MPL in subjects with seasonal allergic rhinitis or rhinoconjunctivitis, induced by grass pollen.

Read more
3 Mar 2021 19:14

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

Read more
3 Mar 2021 13:23

Allergy Therapeutics reports record pre-R&D operating profit

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics reported a 7% improvement in its revenue in actual terms in its interim results on Wednesday, and 5% growth at constant rate, to £54.0m.

Read more
13 Jan 2021 13:29

IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave

IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave

Read more
5 Jan 2021 18:01

IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study

IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study

Read more
5 Jan 2021 16:44

Allergy Therapeutics begins peanut allergy vaccine study

(Sharecast News) - Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blood samples from peanut allergy patients had started at Imperial College London.

Read more
8 Dec 2020 21:07

IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting

IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting

Read more
1 Dec 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
20 Nov 2020 14:51

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.